Similar articles

• Management of necrotizing skin and soft tissue infections.

  De Waele JJ. De Waele JJ. Expert Rev Anti Infect Ther. 2012 Jul;10(7):805-14. doi: 10.1586/eri.12.64. Expert Rev Anti Infect Ther. 2012. PMID: 22943403 Review.
• Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.

  Lipsky BA, Napolitano LM, Moran GJ, Vo L, Nicholson S, Kim M. Lipsky BA, et al. Diagn Microbiol Infect Dis. 2014 Jun;79(2):273-9. doi: 10.1016/j.diagmicrobio.2014.02.011. Epub 2014 Feb 24. Diagn Microbiol Infect Dis. 2014. PMID: 24661685
• Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.

  Cardona AF, Wilson SE. Cardona AF, et al. Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S69-78. doi: 10.1093/cid/civ528. Clin Infect Dis. 2015. PMID: 26316560 Review.
• Establishing the role of tigecycline in an era of antimicrobial resistance.

  Schafer JJ, Goff DA. Schafer JJ, et al. Expert Rev Anti Infect Ther. 2008 Oct;6(5):557-67. doi: 10.1586/14787210.6.5.557. Expert Rev Anti Infect Ther. 2008. PMID: 18847395 Review.
• Complicated skin and soft-tissue infections--consider gram-negative pathogens.

  Ruef C. Ruef C. Infection. 2008 Aug;36(4):295. doi: 10.1007/s15010-008-3408-8. Infection. 2008. PMID: 18663409 No abstract available.